Debra Patt, M.D., Ph.D., MBA, Executive Vice President, Public Policy, Payer Relations, and Strategic Initiatives at Texas Oncology, addressed how the pandemic influenced cancer screening and diagnosis rates. Dr. Patt noted, we’re starting to see later-stage cancer diagnoses, but right now it’s hard to quantify the true extent, and it may take years to fully comprehend how pandemic-related screening delays led to later-stage cancer diagnoses.
Read the full article here.
